BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30334297)

  • 21. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
    Yamada Y; Enokida H; Kojima S; Kawakami K; Chiyomaru T; Tatarano S; Yoshino H; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Cancer Sci; 2011 Mar; 102(3):522-9. PubMed ID: 21166959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH; Choi WS; Kwak C; Kim HH
    Urol Oncol; 2011; 29(4):383-7. PubMed ID: 19556154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-level Ki-67 expression as an independent predictor of bladder tumour recurrence in patients with primary upper tract urothelial carcinoma after radical nephroureterectomy.
    Wu P; Liu S; Zhang W; Zhang Y; Zhu G; Wei D; Wan B; Wang J
    Jpn J Clin Oncol; 2015 Dec; 45(12):1175-81. PubMed ID: 26450700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract--is there evidence for discordant biology?
    Krabbe LM; Lotan Y; Bagrodia A; Gayed BA; Darwish OM; Youssef RF; Bolenz C; Sagalowsky AI; Raj GV; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Apr; 191(4):926-31. PubMed ID: 24060642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.
    Moussa S; Yafi FA; El-Hakim A; Fahmy N; Aprikian A; Tanguay S; Anidjar M; Kassouf W
    Urol Int; 2010; 84(1):50-5. PubMed ID: 20173369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidetector-row computed tomography (MDCT) in patients with a history of previous urothelial cancer or painless macroscopic haematuria.
    Mueller-Lisse UG; Mueller-Lisse UL; Hinterberger J; Schneede P; Meindl T; Reiser MF
    Eur Radiol; 2007 Nov; 17(11):2794-803. PubMed ID: 17404743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location.
    Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C
    BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy.
    Kusuda Y; Miyake H; Terakawa T; Kondo Y; Miura T; Fujisawa M
    Urol Oncol; 2013 Aug; 31(6):899-903. PubMed ID: 21824792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients.
    Yamamoto S; Koyama D; Igarashi R; Maki T; Mizuno H; Furukawa Y; Kuro-O M
    Intern Med; 2020; 59(3):345-355. PubMed ID: 32009088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma.
    Li J; Lu S; Lombardo K; Monahan R; Amin A
    Hum Pathol; 2016 Sep; 55():17-23. PubMed ID: 27137986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.
    Chien CS; Luo HL; Ling CS; Chiang PH; Chen YT; Cheng YT
    Int Urol Nephrol; 2016 Aug; 48(8):1261-1265. PubMed ID: 27193437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Superficial urothelial carcinoma of ureter with elevated serum CA19-9 and CEA].
    Kato S; Yasuda M; Nakano M; Ehara H; Ishihara T; Deguchi T; Sakata Y; Mori H; Shimokawa K
    Hinyokika Kiyo; 2004 Feb; 50(2):99-102. PubMed ID: 15101165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Kidney Disease Is Associated with Increased Plasma Levels of Fibroblast Growth Factors 19 and 21.
    Marchelek-Myśliwiec M; Dziedziejko V; Nowosiad-Magda M; Dołęgowska K; Dołęgowska B; Pawlik A; Safranow K; Wiśniewska M; Stępniewska J; Domański M; Ciechanowski K
    Kidney Blood Press Res; 2019; 44(5):1207-1218. PubMed ID: 31614355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary urothelial carcinoma of the upper tract: important clinicopathological factors predicting bladder recurrence after surgical resection.
    Huang WW; Huang HY; Liao AC; Shiue YL; Tai HL; Lin CM; Wang YH; Lin CN; Shen KH; Li CF
    Pathol Int; 2009 Sep; 59(9):642-9. PubMed ID: 19712132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
    Liu Y; Lu J; Hong K; Huang Y; Ma L
    Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.